ClinicalTrials.Veeva

Menu

Total Body Vitamin A Before and After Vitamin A Supplementation in a Community Where Liver is Frequently Eaten

M

Medical Research Council, South Africa

Status

Completed

Conditions

Hypervitaminosis A

Treatments

Dietary Supplement: Vitamin A supplement

Study type

Observational

Funder types

Other

Identifiers

NCT02915731
EC016-5/2015

Details and patient eligibility

About

This study will assess total body vitamin A pool size, as well as liver vitamin A stores, by means of stable isotope dilution in preschool children from a South African community where liver, an exceptionally rich source of vitamin A, is frequently eaten, and the children exposed to vitamin A fortified staple foods, as well as a vitamin A supplementation programme.

Full description

Serum retinol, the most commonly used indicator to assess vitamin A status, is homeostatically controlled and, although it is able to detect deficiency, it does not necessarily reflect liver stores or measure excessive vitamin A intake. The stable isotope dilution method is able to measure total vitamin A body pool size over the vitamin A status continuum, including the sub-toxic range,and would add valuable information about the vitamin A status in a community where liver (an exceptionally rich source of vitamin A) is frequently eaten, and children also exposed to other vitamin A interventions. Total body vitamin A will be assessed before and 4 weeks after a high dose vitamin A supplement given to the children as part of the national vitamin A supplementation program. The confounding effect of infection/inflammation on the biomarkers of vitamin A status will also be examined, as well as how serum retinol and retinol binding protein relate to each other, and to vitamin A pool size.

Enrollment

95 patients

Sex

All

Ages

36 to 60 months old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Living in the study area;
  • Must not have received a vitamin A supplement in the preceding month

Exclusion criteria

  • Severe anaemia (haemoglobin < 9 g/dL);
  • Fever (body temperature > 38°C)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems